On Friday, the Enforcement Directorate (ED) in India seized more than $280 million from the man believed to be the mastermind behind the OctaFX Ponzi scam. Octa Fx, a platform that promised users accessibility to financial markets on low spread commission-free trading. The ED stated that the suspect, who is a Spanish national, was arrested […]On Friday, the Enforcement Directorate (ED) in India seized more than $280 million from the man believed to be the mastermind behind the OctaFX Ponzi scam. Octa Fx, a platform that promised users accessibility to financial markets on low spread commission-free trading. The ED stated that the suspect, who is a Spanish national, was arrested […]

Indian Authorities Expose Mastermind Behind $280 Million OctaFX Ponzi Scheme

2025/10/19 16:00
Okuma süresi: 3 dk
Ponzi Scheme
  • The Enforcement Directorate (ED) in India seized and arrested the Spanish mastermind behind the OctaFX Ponzi scheme. 
  • According to investigations conducted, OctaFX laundered more than $96 million through fake companies and international bank accounts. 

On Friday, the Enforcement Directorate (ED) in India seized more than $280 million from the man believed to be the mastermind behind the OctaFX Ponzi scam. Octa Fx, a platform that promised users accessibility to financial markets on low spread commission-free trading.

The ED stated that the suspect, who is a Spanish national, was arrested in Spain by local law enforcement officers. According to the agency, this operation was part of India’s ongoing efforts to fight financial crimes under its current anti-money laundering laws.

The Details of the Ponzi Scheme Investigation 

According to the investigations that were conducted, the OctaFX Ponzi scheme deceived thousands of investors in India. Basically, the platform and all its advertisements promised individuals that they could earn huge profits if they invested their money in the OctaFX trading platform, which claimed to specialize in trading different kinds of financial markets like forex, commodities, and cryptocurrency trading. However, these promises quickly turned out to be a lie as investors and traders ended up losing huge amounts of money. 

According to the authorities, the platform gave initial small profits to early investors in order to gain their trust; this method is already a common tactic used in Ponzi schemes. A few weeks before the suspect was arrested, the ED reported that it was investigating OctaFX for illegally moving money abroad. The agency shared that the platform had laundered over $96 million within a period of nine months. 

Also Read: Australia Cracks Down on High-Risk Crypto ATM Amid Massive Fraud

The International Network That Allowed The Ponzi Scheme Run Smoothly

The investigations also revealed that OctaFX had created a large international network of fake companies and bank accounts to hide its criminal activities from being properly tracked. Officials also said this was part of an operation that was carried out in different countries, and it traced how the proceeds from the crypto scheme were turned into digital assets, making them harder to track.

So far the ED recorded that Indian investors have lost about $211,000,000 between July 2022 and April 2023, while the company itself made profits of about $90 million. The platform had been operating since 2019, and according to the investigations, the scheme has made more than ₹5,000 crore (approximately $600 million) from Indian investors over the years, and a large part of this money was secretly transferred overseas through complex financial transactions to avoid detection.

Importantly, authorities also revealed that OctaFX operated through a distributed global network. This system allowed the Ponzi scheme company to evade regulators and disguise its operations as legitimate. All along, the marketing side of the company was managed by businesses based in the British Virgin.

Also Read: Chainlink Price Analysis: $14 Support Zone May Trigger Strong Recovery to $50

Piyasa Fırsatı
Moonveil Logosu
Moonveil Fiyatı(MORE)
$0,0005871
$0,0005871$0,0005871
-%3,50
USD
Moonveil (MORE) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Paylaş
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Paylaş
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26